IL10 and neurodegenerative disease: In this study we found that DHAP inhibited the levels of NO, IL-1β, IL-6, and TNF-α, and enhanced the production of IL-10 in LPS-stimulated macrophages, which suggests that this compound could be an alternative in the treatment of degenerative diseases associated with inflammation, such as rheumatoid arthritis and other chronic diseases.